SHANDONG BOAN BIOTECH.H 1 (UJ9) — Net Asset Quality Index
SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Net Asset Quality Index of 66.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €4.13 Billion minus total liabilities of €1.39 Billion yields net assets of €2.74 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read UJ9 total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
SHANDONG BOAN BIOTECH.H 1 Net Asset Quality Index Over Time (2021–2025)
This chart shows how SHANDONG BOAN BIOTECH.H 1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 66.4%, representing net assets of €2.74 Billion against total assets of €4.13 Billion EUR. For live market cap and overall valuation, see SHANDONG BOAN BIOTECH.H 1 (UJ9) market capitalisation.
Annual Net Asset Quality Index for SHANDONG BOAN BIOTECH.H 1 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for SHANDONG BOAN BIOTECH.H 1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See SHANDONG BOAN BIOTECH.H 1 (UJ9) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.4% | €2.74 Billion | €4.13 Billion | €1.39 Billion | ▲ +8.8 pp |
| 2024 | 57.7% | €1.64 Billion | €2.85 Billion | €1.21 Billion | ▲ +0.9 pp |
| 2023 | 56.8% | €1.32 Billion | €2.32 Billion | €1.00 Billion | ▼ -7.6 pp |
| 2022 | 64.4% | €1.42 Billion | €2.20 Billion | €784.18 Million | ▼ -9.3 pp |
| 2021 | 73.7% | €1.55 Billion | €2.11 Billion | €554.92 Million | — |